New Mexico

Daily

A breathalyzer that detects diseases like TB, hospital-acquired pneumonia gets funded

Seems these days as though breath analysis startups are all the rage – creating diagnostics that provide quick-turnover disease diagnosis. They’re primarily targeted to the public health set – allowing frontline health workers diagnose disease quickly can help expedite intervention time. New Mexico startup Avisa Pharma is developing a breath-based diagnostic that can rapidly detect […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Devices & Diagnostics

Healthcare startup with rheumatology diagnostics closes $25M in debt financing

Albuquerque, N.M.-based Exagen Diagnostics has raised $25 million in debt financing with a strategic investment from Capital Royalty Partners. The healthcare startup focuses on molecular testing innovations in rheumatology diagnostics, including rheumatoid arthritis and lupus, with its Avise line. Sales success attracted the investor. “The company has shown tremendous sales success with their lead product, […]